The University Hospital of Basel, in Basel, is one of the five university hospitals of Switzerland. Since 1842 it is located in a former palace, the Markgräflerhof. USB brings together 50 clinics, units and institutes all working together in an interdisciplinary manner and employs a staff of about 5000.

There are 773 beds in University Hospital Basel, Division of Internal Medicine.

During the past decade, University Hospital Basel, Division of Internal Medicine conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Basel, Division of Internal Medicine" #1 collaborator was "Innosuisse - Swiss Innovation Agency" with 2 trials as a collaborator, "Pharming Technologies B.V." with 2 trials as a collaborator, "Kantonsspital St. Gallen, St. Gallen, Switzerland" with 1 trials as a collaborator, "Swiss National Science Foundation" with 1 trials as a collaborator and "propatient foundation Basel" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Basel, Division of Internal Medicine" are "Acute Ischemic Stroke" (1 trials), "Acute Renal Injury" (1 trials), "Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)" (1 trials), "Coronavirus Infections" (1 trials) and "Epstein-Barr Virus (EBV) Infection" (1 trials). Many other conditions were trialed in "University Hospital Basel, Division of Internal Medicine" in a lesser frequency.

Most popular intervention types in "University Hospital Basel, Division of Internal Medicine" are "Other" (5 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Blood sample collection" (1 trials), "Blood samples for the measurement of the concentration of cefazolin" (1 trials), "Conestat alfa" (1 trials), "Conestat alfa (Ruconest®)" (1 trials) and "Data collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Basel, Division of Internal Medicine" are 9 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital Basel, Division of Internal Medicine". 1 are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University Hospital Basel, Division of Internal Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Basel, Division of Internal Medicine, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".